Emily Cerreta
Family · Houston, TXNPI 1700863909
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,643 of the $3,857 with a category attached, or 68.5%. 34 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 35.3% of the total. Reporting peaked in 2021 at $2,486 and has fallen 99.2% since, to $21 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $26.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- Novo Nordisk$633
- Johnson & Johnson$237
- Boehringer Ingelheim$198
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$121
- AstraZeneca$117
- plus $1K from 28 others
What the payments were for
- Consulting fees$1,20031%
- Food & beverage$2,64369%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 5 | $1,362 |
| Novo Nordisk | 32 | $633 |
| Johnson & Johnson | 16 | $237 |
| Boehringer Ingelheim | 6 | $198 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $121 |
| AstraZeneca | 8 | $117 |
| Boston Scientific | 2 | $112 |
| Sunovion Pharmaceuticals Inc. | 6 | $100 |
| Merck | 7 | $100 |
| Bayer | 7 | $98 |
| Novartis | 6 | $97 |
| Abbott | 4 | $73 |
| Lilly USA, LLC | 5 | $67 |
| GSK | 4 | $60 |
| Exact Sciences | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Inspire Medical Systems, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Amgen | 2 | $32 |
| AbbVie | 2 | $30 |
| Mylan Specialty L.p. | 2 | $25 |
| Sanofi-aventis U.S. LLC | 2 | $24 |
| Bioventus LLC | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
| CMP Pharma, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| GRT US Holding, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Philips North America LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,325
- RYBELSUS$122
- JARDIANCE$122
How this compares
$3,857 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.